Exploring Safety & Clinical Benefit of Anti-Influenza Immune Globulin Intravenous in Hospitalized Adults With Influenza A

Conditions:   Influenza A H3N2;   Influenza A H1N1 Interventions:   Biological: FLU-IGIV;   Other: Placebo for FLU-IGIV Sponsor:   Emergent BioSolutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials